Cargando…
EZH2抑制剂与吉非替尼联合应用在EGFR-TKIs耐药肺癌细胞中的作用研究
BACKGROUND AND OBJECTIVE: Lung cancer is one of the common malignant tumors that impair human health. With the development of epigenetics, the researchers found that enhancer of Zeste homolog 2 (EZH2) is highly expressed in lung cancer tissue and its expression is closely related to the prognosis. E...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533193/ https://www.ncbi.nlm.nih.gov/pubmed/31109434 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.01 |